DeviceClearance

microTargeting Guideline 4000 5.0 System— 510(k) K183123

Substantially Equivalent

FHC, Inc.

FDA 510(k) clearance K183123 for microTargeting Guideline 4000 5.0 System, Substantially Equivalent on 2018-12-20. Applicant: FHC, Inc..

Clearance details

Applicant
FHC, Inc.
Product code
Code GZL
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Bowdoin, ME, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.